Rachel McMinn - Chief Executive Officer, Director at Neurogene Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
NGNE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rachel McMinn since 03 Mar 2025

Holdings reported by Rachel McMinn for Neurogene Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,347,659 $25,457,278 $18.89 20 Feb 2026 Direct
Stock Option (Right to Buy) 155,100 20 Feb 2026 Direct Common Stock
Employee Stock Option (Right to buy) 143,500 26 Mar 2025 Direct Common Stock

Transactions reported by Rachel McMinn for Neurogene Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.